Aclaris Therapeutics, Inc. (ACRS)
NASDAQ · Healthcare
Aclaris Therapeutics, Inc. Long Term Debt 2017–2025
Aclaris Therapeutics, Inc. annual long term debt history from 2018 to 2020. Long term debt refers to financial obligations that are due more than one year in the future.
- Aclaris Therapeutics, Inc. long term debt as of December 31, 2020: 10.7M, a 64.39% decrease year-over-year.
- Aclaris Therapeutics, Inc. long term debt for 2020 were 10.7M, a 64.39% decrease from 2018.
- Aclaris Therapeutics, Inc. long term debt for 2018 were 29.9M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Aclaris Therapeutics, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2020 | $11 |
| 2018 | $30 |
Aclaris Therapeutics, Inc. Long Term Debt — FAQ
Aclaris Therapeutics, Inc. (ACRS) long term debt over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ACRS's long term debt history?
The chart and table above show Aclaris Therapeutics, Inc.'s long term debt by year and by quarter, including the growth rate.